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Dopamine participates in regulating many biological processes. To a large extent it influences the central nervous system and regulates movement control, muscle tension as well as the secretion of prolactin and sex hormones. Disorders connected with dopamine biosynthesis in the central nervous system cause many diseases e.g. Parkinson's disease, chorea. Dopaminergic receptors are also found outside the nervous system e.g. pituitary gland, parathyroid glands, thyroid gland, pancreas, digestive tract and ductus deferens. Dopamine works not only through dopaminergic receptors but also through the adrenergic ones (Anuras 1981; Hovendal et al. 1982; W´grzyn et al. 1988; W´grzyn et al. 1994; Zi´ba et al. 1991) . Dopamine influences organs in many ways, which depends on the organ being examined and an animal's species. Dopamine blocks the motility of both human and canine stomach as well as that of rumen, abomasal and small intestine in ruminants (Bueno et al. 1983; Cebrat et al. 1989; De Carle and Cristensen 1976; W´grzyn et al. 1988; W´grzyn et al. 1994; Zi´ba et al. 1991) . On the other hand, it activates the motility of human duodenum and colon (Anuras 1981; Lanfranchi et al. 1979; Marzio et al. 1986) .
Dopamine has also an activating effect on myometrium. According to Zi´ba (Zi´ba and Dejneka 1996) dopamine administered intravenously to sheep sensitized by stilboestrol causes an increase in uterus myoelectrical activity. The research carried out by Arkinstall and Jones (1985) also confirms the presence of this catecholamine in the uterine smooth muscles of humans, rabbit, sheep, guinea pig and rat. According to Moustafa, activating the dopaminergic receptor with bromocriptine (a selective D 2 -agonist and weak partial agonist at the D 1 receptor) in both in vitro and in vivo experiments causes an increase in myometrial contraction in the early stage of rat pregnancy (Moustafa et al. 1999; Clark and White 1987) .
Because to our knowledge no data are available on myometrial contraction under the effect of dopamine, our research was aimed at the study of the influence of dopamine on this phenomenon in rats under in vitro conditions.
Materials and Methods
The experiments were carried out on 25 Buffalo clinically healthy female rats aged 4-6 months at the weight of 150-170 g. Rats were housed collectively (5-6 rats in the metal cages) at a temperature of approximately 22 °C with a daylight cycle and fed ad libitum the LSM balanced rodent-diet (firm Agropol S.J.). The experiments were carried out with the consent of the Ethical Committee (No. 60/04). The animals were subjected to halothane general anaesthesia and after death their uterus strips 1.5-2 cm long were taken for examination. The strips were placed in 4 automatic bath organs of 20 ml capacity in accordance with the procedure of Alvarez et al. (1988) and Daly et al. (1981) . The KrebsHenseleit buffer (NaCl -118 mM; KCl -4.7 mM; CaCl 2 -2.5 mM; MgSO 4 -1.6 mM; NaHCO 3 -24.3 mM; KH 2 PO 4 -1.18 mM; glucose 5.6 mM) (Coruzzi et al. 1988 ) was used as an incubation environment. The incubation of strips was conducted at the temperature of 37 °C, loaded with 1 g and the oxygen and carbon dioxide gas mixture (95% O 2 and 5% CO 2 ) was added so that its pH remained within 7.3-7.5. Myometrial contractions were recorded by isometric transducers (Letica Scientific Instruments) connected to BridgeAmp amplifiers (ADInstruments, Australia) with 4 channel data acquisition system (PowerLab/400, ADInstruments) connected to a Macintosh computer. After a 30-min recording of spontaneous myometrial contraction activity the following were added into the bath organs In order to determine the effective dose the substances were added to the incubation bath ranging from the lowest dilution to the highest one in the dose concentration system (that is without rinsing the bath between the subsequent additions of the doses to the bath). The lowest substance concentration that yielded an evident result on the recording was accepted as the experimental dose and was confirmed in a number of following experiments.
The frequency of contractions per min and the strength of contractions given in grams were taken into consideration while summarizing the obtained results.
The results were summarized in the Microsoft Excel 2000 and analyzed statistically using the Student's t-test and the analysis of variance (ANOVA).
Results
The uterus strips placed in the automatic bath organ exhibited periodical contractility with a frequency of 1.15 ± 0.38 contraction per min. The strength of the single contraction was on average 2.8 ± 0.45 g.
The addition of dopamine to the incubation bath organ at a concentration of 0.26·10 -4 mol/L per bath organ did not cause any statistical differences in uterus motility, but at a concentration of 1.3·10 -4 mol/L caused a decrease in both the frequency (27% (p < 0.01), to the value 0.84 ± 0.21 per minute) and strength (63% (p < 0.001) to 1.04 ± 0.18) (hypotonia), and a total lack in spontaneous contractility at a concentration of 2.6·10 -4 mol/L (atony) (Figs 1, 2, 3) .
The attempt at blocking D 1 dopaminergic receptors with metoclopramide, domperidone and clozapine did not prevent from uterus atony caused by the addition of dopamine (Figs 4, 5, 6) . Uterus contractility was not affected by activating dopaminergic receptors with bromocriptine and the obtained recording exhibited no statistically significant differences in comparison to the initial recording. Simultaneous blocking of β 1 adrenergic receptors with prazosine, and β adrenergic receptors with propranolol counteracted uterus atony caused by the addition of dopamine to the incubation bath (Fig. 7) . 
Discussion
Administration of dopamine to animals causes different, often opposing reactions dependent both on the examined organs and the species. Dopamine influences organs not only through dopaminergic receptors but also through the adrenergic ones. According to W´grzyn et al. (1994) dopamine blocks the motility of abomasum through D 2 dopaminergic and α-adrenergic receptors. Dopamine has also a blocking effect on the motility of ileum through α-adrenergic receptors (Zi´ba et al. 1991) .
As far as uterine smooth muscles are concerned the presence of cell membrane receptors including the dopaminergic ones is strongly related to hormones, mainly oestrogens. Other authors also emphasize the importance of oestrogens in changing the concentration of different cell membrane receptors (Ayad et al. 1989; Gilbert et al. 1992; Massmann et al. 1991; Sheldrick and Flint 1985) . Arkinstall and Jones (1985) indicated the presence of endogenous dopamine in uterus muscles, and Forsberg et al. (1987) exhibited the influence of dopamine on rat uterus cervix contractility. According to Zi´ba and Dejneka (1996) dopamine stimulates uterine myoelectrical activity in sheep sensitized by stilboestrol and its stimulating effect is not carried out by dopaminergic receptors. An increase in uterine pressure is caused by administration of dopamine to pregnant sheep (Fishburne et al. 1980) . A similar increase in uterine contractility is noticed in women after the infusion of dopamine (Urban et al. 1982 ). An increase in uterus contractility is also noticed after the administration of bromocriptine (the agonist of dopaminergic receptors) to rats in early pregnancy (for the period of 11 days beginning from the 9th day) (Moustafa et al. 1999) .
Dopamine stimulates uterine contractility in rabbits, rats and women in early pregnancy (L a l and Sharma 1983; Sizov 1992; Urban et al. 1982; Ekesbo et al. 1991) . It blocks muscle relaxation effect caused by releasing relaxin during parturition (Sizov 1992) . The stimulating effect of dopamine and bromocriptine on uterus contractility in vivo is related to the fact that they increase the level of vasopressin (vasopressin stimulates uterus contractility), and decrease the concentration of PGI 2 (PGI 2 blocks uterus contractility) in the uterus (Robinson et al. 1982; Hauksson et al. 1988; Ageel et al. 1985) .
The uterine strips placed in the automatic bath organ exhibited periodical contractility as confirmed by earlier experiments carried out by and other authors (Estan et al. 1988; Parija et al. 2001 ). The addition of dopamine to the incubation bath organ at a concentration of 2.6·10 -4 mol/L resulted in atony of the isolated strip. Similarly, Estan et al. (1988) obtained atony of the isolated strips in rats after the addition of dopamine at a concentration of 10 -7 to 10 -4 mol/L. The decrease in uterine contractility was in direct proportion to the concentration of dopamine in the bath organ. On the contrary, Lechner et al. (1996) obtained an increase in uterus activity in vitro after the addition of dopamine at a concentration of 10 -6 mol/L. Blocking dopaminergic receptors with metoclopramide, domperidone and clozapine did not prevent from atony after the addition of dopamine. The obtained results indicated that the blocking effect of dopamine on uterus contractility was not carried out through dopaminergic receptors (Estan et al. 1988) .
According to Lechner et al. (2000) the addition of metoclopramide blocks spontaneous contractility of the isolated uterus strips removed from women during a caesarean section. The blocking effect of metoclopramide was not observed in our research. A different hormonal profile of a female (pregnancy) as well as a different species can change the influence of metoclopramide on spontaneous contractility. Dopamine can also influence organs through adrenergic receptors (e.g. W´grzyn et al. 1994; Zi´ba et al. 1991) .
Stimulating adrenergic receptors with selective agonists, except for α 2 -adrenergic ones which has an activating effect, blocks uterus contractility in rats in vitro (C z e r s k i et al. 2004) . In other animal species, for example in sheep, it can be different. Blocking adrenergic receptors with prazosine (the antagonist of α 1 -adrenergic receptors) and with propranolol (the antagonist of both subtypes of β-adrenergic receptors) prevented from atony of uterus muscles after the addition of dopamine. Dopamine could cause uterine atony through stimulating adrenergic receptors. Similarly, Estan et al. (1988) also obtained a blocking effect of dopamine on uterus contractility carried out through β-adrenergic receptors. However, blocking β-adrenergic receptors with propranolol or blocking α 1 -adrenergic ones with prazosine did not counteract uterine atony after the addition of dopamine. It was simultaneous blocking of both β-adrenergic and α 1 -adrenergic receptors that counteracted the influence of dopamine on spontaneous contractility.
Úãinek dopaminu na motilitu dûlohy potkanÛ in vitro
Byl zkoumán úãinek dopaminu na spontánní rytmické kontrakce izolovan˘ch svalov˘ch bunûk dûlohy potkanÛ. Experimenty byly provedeny na 25 samicích potkanÛ Buffalo, ve vûku 4-6 mûsícÛ. TkáÀ myometria (1,5-2 cm dlouh˘ prouÏek) byla vloÏena do 4 izolovan˘ch orgánov˘ch lázní (20 ml) o 37 °C. Po zaznamenání rytmu spontánní motility tkánû myometria byly do orgánov˘ch lázní aplikovány: dopamin, domperidon, metoclopramid, clozapin, bromocriptin, prazosin a propranolol. Dávka látek byla stanovena v pfiedbûÏn˘ch pokusech. ProuÏky myometria inkubované v izolovan˘ch orgánov˘ch lázních vykazovaly spontánní motilitu po dobu cca 8 aÏ 12 hodin. Frekvence spontánní motility se pohybovala kolem 1,15 ± 0,38 kontrakcí za minutu. Síla kontrakce byla prÛmûrnû 2,8 ± 0,45 gramÛ. Pfiidání dopaminu do orgánové inkubaãní láznû v koncentraci 1,3·10 -4 mol·l -1 signifikantnû sníÏilo sílu (63%, p < 0,001, na hodnotu 1,04 ± 0,18 gramÛ) a frekvenci (27%, p < 0,01, na hodnotu 0,84 ± 0,21 za minutu) spontánních rytmick˘ch kontrakcí. Pfiidání dopaminu v koncentraci 2,6·10 -4 mol·l -1 zcela inhibovalo spontánní rytmické kontrakce dûlohy. Pokus o blokování dopaminergních receptorÛ metoclopramidem, domperidonem a clozapinem nezabránilo atonii dûlohy zpÛsobené pfiidáním dopaminu. Kontraktilita dûlohy nebyla ovlivnûna aktivací dopaminergních receptorÛ bromokriptinem, agonistou D 1 a D 2 receptorÛ, a získané záznamy neprokázaly Ïádné statisticky v˘znamné rozdíly ve srovnání s v˘chozími. Simultánní blokování α 1 adrenergních receptorÛ prazosinem a β adrenergních receptorÛ propranololem pÛsobilo proti atonii dûlohy po pfiidání dopaminu do inkubaãní orgánové láznû.
V˘sledky ukazují blokující úãinek dopaminu na kontraktilitu dûlohy potkanÛ in vitro závisl˘ na koncentraci dopaminu a zpÛsoben˘ aktivací adrenergních receptorÛ dopaminem.
